Liu M Z, Huang Y S, Xiao W Q
Shanghai Institute of Materia Medica, Chinese Academy of Sciences.
Zhongguo Yao Li Xue Bao. 1991 Nov;12(6):534-7.
From d 3 after transplantation of Lewis pulmonary carcinoma in C57BL mouse leg muscles, the mice were injected ip sodium tanshinone II-A sulfonate (DS-201) 0.2, 0.4, 6.3, 12.5, 25.0, and 50.0 mg.kg-1 qd x 12 d. At the dose of 12.5 mg.kg-1 or below, the mice appeared to be as vivid as those of the control. In the group of 25 mg.kg-1, declining brisk and unkept appearances were seen. At 50 mg.kg-1, the mice were more emaciated and half of them died. On d 2 of cessation of the medication, all remaining mice were dissected. The weights of muscle tumors and the metastatic foci on lungs in the medicated mice showed no significant differences from their controls. These results demonstrate that DS-201 has no promoting effect both on growth of Lewis carcinoma transplanted in C57BL mouse leg muscles and on lung metastasis of the neoplasm.
在C57BL小鼠腿部肌肉接种Lewis肺癌后的第3天起,给小鼠腹腔注射丹参酮Ⅱ-A磺酸钠(DS-201),剂量分别为0.2、0.4、6.3、12.5、25.0和50.0mg·kg-1,每日1次,共12天。剂量在12.5mg·kg-1及以下时,小鼠表现与对照组一样活泼。25mg·kg-1组小鼠活动减少,外观不佳。50mg·kg-1组小鼠更加消瘦,半数死亡。停药第2天,解剖所有存活小鼠。用药小鼠的肌肉肿瘤重量及肺部转移灶与对照组相比无显著差异。这些结果表明,DS-201对C57BL小鼠腿部肌肉移植的Lewis癌生长及肿瘤肺转移均无促进作用。